Cryopreserved ampule of Normal Human Dendritic Cells (NHDC) containing ≥2.5 million cells
Cryopreserved ampule of Human Peripheral Blood CD14+ Monocytes, positive selection, containing ≥20 million cells
Do you need a modified version of this cell product, such as different vialing sizes, matched immune cell isolations or isolations from special donors or species? Contact Lonza CellBio Services to discuss custom isolation, expansion, and testing options for your research
Cryopreserved ampule of Human Peripheral Blood CD14+ Monocytes, positive selection, containing ≥10 million cells
Do you need a modified version of this cell product, such as different vialing sizes, matched immune cell isolations or isolations from special donors or species? Contact Lonza CellBio Services to discuss custom isolation, expansion, and testing options for your research
Cryopreserved ampule of Human Peripheral Blood CD14+ Monocytes, positive selection, containing ≥40 million cells
Do you need a modified version of this cell product, such as different vialing sizes, matched immune cell isolations or isolations from special donors or species? Contact Lonza CellBio Services to discuss custom isolation, expansion, and testing options for your research
Cryopreserved human leukapheresis product (≥9.5 billion cells)
Cryopreserved human leukapheresis product (≥5.0 billion cells)
Cryopreserved ampule of Human Peripheral Blood Mononuclear Cells (hPBMC) containing ≥ 50 million cells with population frequency information
Cryopreserved ampule of Human Peripheral Blood Mononuclear Cells (hPBMC) containing ≥ 100 million cells with cell type frequency information
-
Viable Cells - Proliferating Clonetics™ Cells Chart
-
Cell-based Assays Using Hard-to-transfect Cell Lines and Transiently Transfected Primary CellsCo-sponsered poster with Promega
-
Cell Therapy Capabilities
-
Mitosis of CD34+ cells with Nanolive's 3D Cell Explorer -
Primary Cells as Tools in Advanced Cell Culture Models -
CD34+ Cells for Cell and Gene Therapy Process DevelopmentIn this interview Dr. Manon Destalminil, Bioprocessing Project Leader at CellProthera, discusses the advantages of using research-grade CD34+ cells for cell and gene therapy process development. Please register to read.
-
Luminescent Cell-Based AssaysLearn more about Lonza's luminecent cell-based assay offerings
-
Instructions - Prostate Cell SystemsInstructions for culturing Clonetics™ Human Prostate Cells
-
Instructions - Renal Cell SystemsInstructions for culturing Clonetics™ Human Renal Cells
-
TechSheet - Keratinocyte Cell SystemsTechnical information sheet for Clonetics™ for Keratinocyte Cell Systems